Clarified Precision Medicine combines an AI and machine-learning platform with a medical group to help oncologists interpret genomic test results and select personalized cancer treatments. Its asynchronous molecular tumor board provides expert-reviewed, guideline-based therapy options from a patient’s tumor profile. ClarifiedSelect supports treatment guidance; OncoGuardian provides pharmacogenomics and gene-to-drug risk guidance; ClarifiedData supports oncology data analysis and discovery. The company also helps institutions build and sustain their own precision medicine tumor boards. It serves oncology providers, payers, testing laboratories and life-science organizations, with medical experts reviewing recommendations before they are used in clinical workflows.
Daniel RotroffChief Technology Officer
Howard McLeodCo-Founder and Medical Director
Lincoln NadauldCo-Founder
Lisa AldersonCo-Founder; Scientific Advisor (published affiliation; current advisory membership unverified)
Rich SchilskyBoard Member
Roy BeveridgeBoard Member